Knowledge Is Power, but Is Ignorance Bliss? Optimising Conversations About Disease Progression in Multiple Sclerosis Patrick VermerschJane ShanahanSven Schippling Commentary Open access 20 November 2019 Pages: 1 - 10
Cladribine Tablets and Relapsing–Remitting Multiple Sclerosis: A Pragmatic, Narrative Review of What Physicians Need to Know Mohamed AlJumahMona Marwan AlkhawajahPeter Rieckmann Review Open access 13 February 2020 Pages: 11 - 23
Current Directions in Deep Brain Stimulation for Parkinson’s Disease—Directing Current to Maximize Clinical Benefit Aristide MerolaAlberto RomagnoloLeo Verhagen Review Open access 09 March 2020 Pages: 25 - 41
Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing–Remitting Multiple Sclerosis Patients? A Narrative Review Isa Ahmed AlSharoqiMohamed AljumahPer Soelberg Sørensen Review Open access 15 April 2020 Pages: 55 - 66
Real-World Treatment of Patients with Multiple Sclerosis per MS Subtype and Associated Healthcare Resource Use: An Analysis Based on 13,333 Patients in Germany Sabrina MüllerTobias HeidlerThomas Wilke Original Research Open access 12 December 2019 Pages: 67 - 83
A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis Michelle AllanLindsay Grant Original Research Open access 13 December 2019 Pages: 85 - 92
Care Among Migraine Patients in a Commercially Insured Population Machaon BonafedeDonna McMorrowStephen Silberstein Original Research Open access 15 February 2020 Pages: 93 - 103
Evaluation of Mortality During Long-Term Treatment with Tafamidis for Transthyretin Amyloidosis with Polyneuropathy: Clinical Trial Results up to 8.5 Years Giampaolo MerliniTeresa CoelhoBen Ebede Original Research Open access 27 February 2020 Pages: 105 - 115
Cost-Effectiveness of IncobotulinumtoxinA in the Treatment of Sialorrhea in Patients with Various Neurological Conditions Koji MakinoNeil MahantLara Aghajanian Original Research Open access 12 March 2020 Pages: 117 - 133
Impact of Non-Cardiac Clinicopathologic Characteristics on Survival in Transthyretin Amyloid Polyneuropathy Alejandra González‐DuarteIsabel ConceiçãoMichelle Stewart Original Research Open access 31 March 2020 Pages: 135 - 149
Potentially Inappropriate Medications in a Psychogeriatric Inpatient Ward: An Audit Based on Beers Criteria Isabelle MoebsEsther AbelnYoram Barak Original Research Open access 17 April 2020 Pages: 151 - 157
Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife Minos KritikosSean A. P. CloustonBenjamin J. Luft Original Research Open access 30 April 2020 Pages: 159 - 171
Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing–Remitting Multiple Sclerosis: Quantifying the Patient’s Perspective José Meca-LallanaJorge MaurinoJavier Ballesteros Brief Report Open access 18 January 2020 Pages: 173 - 179
Tardive Reactivation of Progressive Multiple Sclerosis During Treatment with Biotin Alexis DemasJean-Philippe CochinPierre Labauge Case Report Open access 19 December 2019 Pages: 181 - 185
A Case Report of Myoclonus-Dystonia with Isolated Myoclonus Phenotype and Novel Mutation Successfully Treated with Deep Brain Stimulation Valentina Besa LehmannMarc RosenbaumLeo Verhagen Metman Case Report Open access 09 April 2020 Pages: 187 - 191
Correction to: Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing–Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMSII Trials Angelo GhezziTanuja ChitnisDaniela Pohl Correction Open access 14 February 2020 Pages: 193 - 195